> BIOSPAIN
Press Releases

SHARE THIS INFORMATION

BioSpain 2014 expands its Investment Forum through wider range of investor profiles and more participating companies

The new format puts further emphasis on the presence of international capital risk funds and opens the door to other investor profiles (such as business angels, industrial capital and crowdfunding platforms)

Madrid, 13 June 2014. Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the sector, for which 23 investment funds - 70% of which are international- have already confirmed their attendance, a figure the organisers expect to double.

 

This year the Forum will be bolstered by the presence of a wider range of investor profiles, a bigger international presence and more participating companies.  

 

There are currently 10 available slots for companies and other entities wishing to pitch a business plan to the attending investors. In total, there will be 40 presentations over the three day duration of Biospain, each lasting 8-10 minutes, with alternating conferences on a wide range of investment issues (including corporate funds for big pharma, large international funds, PPP initiatives, business angels, industrial capital from non-pharma sectors and crowdfunding, to name a few).   

 

Among the most important funds to attend Biospain feature companies such as Aravis Ventures (Switzerland), Caixa Capital Risc (Spain), Cross Road Biotech (Spain), Edmond de Rothschild Investment  Partners (France), Forbion Capital Partners (Netherlands), Index Ventures (Switzerland), Johnson & Johnson Development Corporation (UK), LG Life Sciences (South Korea), Merck Serono Ventures (Germany), Novartis Venture Fund (Switzerland), Sofinnova Partners (France), Takeda Ventures (US), Ysios Capital Partners (Spain), Glaxo SmithKline Pharmaceuticals (UK) y Warburg Pincus (UK).

 

Company participation fees are 1000 euros for ASEBIO members and 1500 euros for non-members. The fee includes:

 

 

●      Full registration and access for BioSpain 2014 (including partnering system)

●      8-10 minute presentation slot in one of the Investment Forum sessions

●      Access to VIP area

●      Company profile summary in the Investment Forum section of the BioSpain 2014 catalogue

●      Inclusion in email summary - profiles of those presenting projects at the Investment Forum - for the investors attending Biospain 2014 (prior to the event)

 

 

BioSpain 2014 (www.biospain2014.org), the 7th International Biotechnology Conference, is a biennial event which will take place from the 24th to the 26th of September in the Palacio de Congresos y Exposiciones de Galicia (Galicia Conference Centre), Santiago de Compostela (A Coruña). It is organised by the Spanish Bioindustry Association (ASEBIO) and on this edition, also by the Autonomous Government of Galicia, the University of santiago de Compostela, the University of Vigo and Santiago City Council.

 

Stand space at the trade fair is experiencing high demand, with 80% already allocated to exhibitors.  

 

So far we can confirm the attendance of over 100 companies and other entities from 20 countries, including delegations from countries such as Portugal, Canada, Colombia, Mexico, Russia, the UK and India. Biospain expects to attract 2000 participants - 10% more than in 2012 - exceeding the benchmark set that year of 800 companies and institutions from 40 countries.

 

BioSpain 2014 is sponsored by Bioibérica, Merck, MSD, Zeltia Group, Roche Institute and CLAMBER (Castilla La Mancha Bioeconomy Region).

 

To browse the complete list of over 400 companies and entities from 20 countries which have already registered for the event, please click here

 

 

 

 

 

 

For further information:

 

Lucía Cecilia

Head of Communications for BioSpain 2014 and ASEBIO

landline. + 34 912109374/10

mobile: + 34 663 117 293          

e-mail: lcecilia@asebio.com / lcecilia@biospain2014.org

www.asebio.com

 

 

BioSpain 2014 Press Office: BERBÉS ASOCIADOS

Jorge Sánchez / Irene Fernández

landline: 91 563 23 00 / 678 544 149 / 661 67 82 83

E-mail:jorgesanchez@berbes.com / irenefernandez@berbes.com

 

Twitter: @BioSpain2014 (https://twitter.com/BioSpain2014)

Linkedin Group: ‘BioSpain 2014’

 

 

 

 

 

 

Inversores de 11 países analizan 30 proyectos de biotecnología española 

Read more

El top ten de fondos de inversión asistentes a Biospain 2016 gestionan activos valorados en más de 5.000 millones de euros

Read more

The ten biggest funds at Biospain 2016 manage assets of over 5 billion euros

Read more

Los pacientes piden en Biospain 2016 una participación activa en las políticas de salud y en el sistema sanitario 

Read more

El descubrimiento del ‘GPS humano’ abre una nueva era en la ingeniería genética

Read more

La biotecnología agrícola, clave para afrontar el problema de la superpoblación y el cambio climático

Read more

Biospain 2016 ya cuenta con una APP gratuita para seguir el evento

Read more

US expects to increase its presence in Biospain 2016

Read more

Bilbao will host BioSpain 2016

Read more

BioSpain 2016 will be the hub of Biotechnology in Autumm

Read more

Bilbao acogerá BioSpain 2016

Read more

EE.UU. prevé incrementar su presencia en Biospain 2016

Read more

BioSpain 2016 selecciona a cuatro sociedades científicas

Read more

El 82% de los asistentes a Biospain identificaron oportunidades reales de negocio

Read more

82% of participants at Biospain identified real business opportunities

Read more

La inmunoterapia se postula como uno de los pilares terapéuticos del cáncer

Read more

La bioimpresión 3D de tejidos tisulares acortará el tiempo de desarrollo de fármacos de 10 a tres años

Read more

La bioeconomía se consolida como una herramienta clave para afrontar los retos futuros del planeta

Read more

BioSpain 2014 incrementa un 43% su internacionalización sobre la edición anterior

Read more

BioSpain 2014 increases its internationalisation by 43% compared to the previous edition 

Read more

Participantes en Biospain de 16 países llegarán a la feria por el camino #Xacobio

Read more

La biotecnología agroalimentaria tendrá una importante presencia en BioSpain 2014

Read more

Biospain firma un acuerdo con Febiotec para la or-ganización del II Foro de Formación y Empleo

Read more

BioSpain 2014 amplía su Foro de Inversión con más perfiles de inversores y más empresas participantes

Read more

BioSpain 2014 refuerza su presencia internacional e incorpora el modelo de “Innovación en abierto”

Read more

BioSpain 2014 strengthens its international presence and includes ‘Open Innovation’ model 

Read more

10 scientific and medical societies collaborate on Biospain 2014 programme 

Read more

10 scientific and medical societies collaborate on Biospain 2014 programme  

Read more

Biospain 2014 contará en su programa con la colaboración de 10 sociedades científicas y médicas

Read more

Biospain 2014 abre su programa de conferencias a las sociedades científicas y médicas

Read more

ASEBIO y la Xunta de Galicia sellan su colaboración en BioSpain 2014

Read more

ASEBIO and the Autonomous Government of Galicia seal their collaboration on BioSpain 2014

Read more

Santiago de Compostela será la capital europea de la biotecnología en 2014

Read more

Xacobio